Long-term follow-up of fertility preservation in women after cancer remission
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
This project will see how fertility preservation options work long-term for women in remission from cancer or hematological disease, including how often preserved material is used and the psychological effects.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 102 (estimated) |
| Ages | 18 Years to 47 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Trial ID | NCT07312058 on ClinicalTrials.gov |
What this trial studies
This observational project at CHU Amiens Picardie will document clinical pathways, decisions made at the time of fertility preservation consultation, the techniques used, and reproductive outcomes observed after remission. Researchers will collect clinical records and follow-up data and gather patient-reported information on use of preserved gametes and psychological impact. The cohort includes women aged 18–47 who had a fertility preservation consultation and are currently in remission. Findings aim to identify gaps in care and inform improvements in counseling and long-term follow-up.
Who should consider this trial
Good fit: Women aged 18–47 who underwent a fertility preservation consultation, are currently in remission, and are followed at CHU Amiens Picardie are the intended participants.
Not a fit: Patients who are not in remission, are not followed at CHU Amiens Picardie, are male, or who did not have a fertility preservation consultation are unlikely to benefit from this project.
Why it matters
Potential benefit: If successful, the work could improve counseling, follow-up care, and decision-making around fertility preservation for women treated with gonadotoxic therapies.
How similar studies have performed: Previous studies have reported some outcomes of fertility preservation, but long-term real-world use of preserved material and the psychological consequences remain relatively under-studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women * Aged between 18 and 47 years * Diagnosed with cancer or hematological disorders requiring potentially gonadotoxic treatment * Having undergone a medical fertility preservation consultation * Followed at Amiens Picardie University Hospital (CHU Amiens Picardie) in the department of Reproductive Medicine * Currently in remission * Having expressed non-opposition to participation in the study Exclusion Criteria: * Absence of remission * Patients deprived of liberty by administrative or judicial decision, or placed under legal protection (guardianship or curators) * Decline to participate in the study
Where this trial is running
Amiens
- CHU Amiens Picardie — Amiens, France (Recruiting)
Study contacts
- Study coordinator: CABRY-GOUBET Rosalie, Pr
- Email: cabry.rosalie@chu-amiens.fr
- Phone: 33+3 22 08 80 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.